E.g., 03/18/2024
E.g., 03/18/2024
Title Category Credit Event date Pricesort descending
Update Series Volume 29-38 (2010-2020) $0.00 The AUA Update Series (2010-2020) allows you to access previous subscriptions. This resource is available to all previous subscribers and AUA Members. All lessons as well as a full table of contents are available for each year. Note: This resource does not contain post-tests or CME.  
Refractory Overactive Bladder: How to Select 3rd Line Therapies and Optimize Outcomes Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Upon completion, participants will be familiar with third-line therapies available to treat refractory overactive bladder (OAB), including the pros and cons of each option, the current data regarding outcomes to facilitate proper patient counseling and optimal techniques to maximize the success of the various therapies. The case-based format will provide real-world scenarios by which to learn about the implementation of successful third-line options.
Update Series (2016) Lesson 25: The Role of Bladder Preservation Therapy for Muscle Invasive Bladder Cancer $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Treatment for Hormone Sensitive Prostate Cancer Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00
Update Series (2015) Lesson 1: Erectile Dysfunction in the Younger Man $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2023) Lesson 32: Localized Prostate Cancer AUA Guideline 2022
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Webcast (2023)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice (2023) is an exciting new educational initiative to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course features a Moderator and three other subject matter experts engaging in an interactive, interview-style presentation and discussion.  
Update Series (2015) Lesson 17: Delayed Ejaculation: A Condition Whose Time Has Come $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2024) Lesson 7: Updates in Critical Care Management in the Urologic Patient
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Audio Lessons - Listen on-the-go for Free!Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?Add the Update Series Audio Lessons to Your Podcast Library Today!Please follow the download instructions to your preferred Podcast app, located below. 
Update Series (2015) Lesson 33: Cytoreductive Nephrectomy in the Age of Targeted Systemic Therapy $0.00 For the most timely topics and latest surgical techniques in urology, you won’t want to miss the 2015 AUA Update Series—the AUA’s most popular self-study CME product.All new topics for 2015!
Update Series (2021): Test Your Knowledge 36-40 $0.00 For our annual subscribers, we are excited to continue to offer a new feature to the Update Series! If you like to answer questions to help you study and learn, we are now offering Test Your Knowledge activities with each release of the Update Series.This new feature:
Advanced Practice Provider Core Curriculum: Kidney Stones & Dietary Considerations (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Member only benefit! Results of a recent survey sent to US based practicing urologists show that there has been an increase in the number of advanced practice providers (APPs) actively providing front-line urologic care. Based on these findings, it was determined that the AUA develop a modular curriculum to be used in advancing the standard of urologic education for APP’s. This educational curriculum, developed in partnership with the Cleveland Clinic, is comprised of online videos targeted towards the most common reasons patients seek non-operative urologic care.
Update Series (2016) Lesson 9: Female Reproductive Medicine for the Urologist $0.00 For the most timely topics and latest surgical techniques in urology, you won't want to miss the 2016 AUA Update Series—AUA's most popular self-study CME product.Concise, practical lessons on timely topicsState-of-the-art surgical techniquesAuthors are among the best in their specialtiesEarn up to 40 AMA PRA Category 1 Credits™
Building a Primary Palliative Care Model for Urology Webcast (2021)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Building a Primary Palliative Care Model for Urology Webcast (2021) discusses aspects of palliative care that benefit patients, the urologist’s role and their collaboration with palliative care clinicians including:
The Changing Face of Advanced Prostate Cancer Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 This is an ongoing course on advanced prostate cancer at the AUA Annual Meeting since 2012, and the changes over the last decade have been nothing less than breathtaking! In the early years, it was all about metastatic castrate-resistant prostate cancer (CRPC) with multiple new therapeutic advances starting in 2010, followed by abiraterone and enzalutamide and a focus on bone-targeted agents.

Pages